Latest Chemokine Stories
Chemokine Therapeutics Corp. ("Chemokine Therapeutics" or the "Company") (TSX: CTI)(OTCBB: CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular disease today announced that research results were presented yesterday by the laboratory of Dr.
New research has found that a gene variant may make Africans more vulnerable to HIV infection, while also helping them live longer once infected. The genetic variation originated thousands of years ago to protect Africans from malaria, the researchers said Wednesday.
Compugen has announced positive results from a recently completed in vivo study of CGEN-25007, a novel peptide antagonist of the gp96 protein.
Compugen Ltd. (NASDAQ:CGEN) announced today positive results from a recently completed in vivo study of CGEN-25007, a novel peptide antagonist of the gp96 protein.
Chemokine Therapeutics Corp. (the "Company") (TSX: CTI)(OTCBB: CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders and vascular diseases, today announced that it has been granted U.S. Patent No. 7,378,098. Patent No.
RICHMOND, Calif., June 30 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. announced today the publication of data demonstrating that human immune system cells (CD4 T-cells) can be made resistant to HIV infection by treatment with zinc finger DNA-binding protein nucleases (ZFN(TM)).
A new method of filming blood-vessel cells that move in accordance with targeted signals has been developed by researchers at Uppsala University in collaboration with researchers at the University of California. The method can also be used to study how migration of cancer cells and nerves can be controlled. These interesting findings have now been published in the Journal of Biological Chemistry.
A new Vanderbilt University study has identified a chemical signal that plays a critical role in forming the heart, which could lead to new strategies to combat congenital heart defects.
Physicians might one day be able to treat a disease that destroys brain cells in children using genetically modified cells to transport a "drug" to the site of the dying neural cells.
- In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.